Moderna shares rise 8% after U.S. passenger tests positive for hantavirus on cruise ship

Moderna's stock jumped 8% in premarket trading following news that a U.S. passenger on the MV Hondius cruise ship tested positive for the Andes strain of hantavirus. All 17 U.S. citizens on board are being repatriated. The development has drawn attention due to the potential health risks associated with hantavirus, though the broader impact on Moderna's business remains unclear. Investors are watching closely for any further updates.